Potential impact of USPSTF recommendations on early diagnosis of breast cancer

Annals of Surgical Oncology

Volumn 18, Issue 11, 2011, Pages 3137-3142

  Aragon, Robert ^a   Morgan, John ^b   Wong, Jan H ^c   Lum, Sharon ^a,b  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOMA LINDA UNIVERSITY   (United States)

^c EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; HORMONE RECEPTOR;

ADULT; AGED; ASIAN; CANCER REGISTRY; CANCER SCREENING; CONFERENCE PAPER; CONTROLLED STUDY; DEMOGRAPHY; EARLY DIAGNOSIS; FEMALE; HISPANIC; HUMAN; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; PACIFIC ISLANDER; PRACTICE GUIDELINE; SOCIAL STATUS;

ADULT; ADVISORY COMMITTEES; AGE FACTORS; AGED; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; EARLY DETECTION OF CANCER; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; NEOPLASM STAGING; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; SEER PROGRAM; SURVIVAL RATE;

EID: 83055165758     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1915-9     Document Type: Conference Paper

References (35)

1. Altekruse SFKC, Krapcho M, et al. (eds) SEER cancer statistics review, 1975-2007, based on November 2009 SEER data submission, posted to the SEER web site, 2010. Bethesda, MD: National Cancer Institute. 2010. http://seer.cancer. gov/csr/1975-2007/. Accessed 1 April, 2011.
2. Berry DA, Cronin KA, Plevritis SK, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353(17):1784-92.
3. Mandelblatt JS, Cronin KA, Bailey S, et al. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med. 2009;151(10):738-47.
4. Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet. 2002;359(9310):909-19.
5. Cady B, Michaelson JS, Chung MA. The "tipping point" for breast cancer mortality decline has resulted from size reductions due to mammographic screening. Ann Surg Oncol. 2011;18(4):903-6.
6. Virnig BA, Wang SY, Shamilyan T, Kane RL, Tuttle TM. Ductal carcinoma in situ: risk factors and impact of screening. J Natl Cancer Inst Monogr. 2010; (41):113-16.
7. Hofer BM KS, Allen M, Bates JH, Snipes KP. Cancer in california 1988-2007. Sacramento, CA: California Department of Public Health, Cancer Surveillance Section.
8. Smith RA, Duffy SW, Gabe R, Tabar L, Yen AM, Chen TH (2004) The randomized trials of breast cancer screening: what have we learned? Radiol Clin North Am. 42(5):793-806.
9. Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial. Lancet. 2006;368(9552):2053-60.
10. U. S. Preventive Services Task Force. Screening for breast cancer: U. S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151(10):716-26, W-236.
11. Newman LA. Breast cancer in African-American women. Oncologist. 2005;10(1):1-14.
12. Newman LA, Griffith KA, Jatoi I, Simon MS, Crowe JP, Colditz GA. Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status. J Clin Oncol. 2006;24(9):1342-9.
13. Yost K, Perkins C, Cohen R, Morris C, Wright W. Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control. 2001;12(8):703-11.
14. Olaya W, Wong J, Morgan J, et al. Factors associated with variance in compliance with a sentinel lymph node dissection quality measure in early-stage breast cancer. Ann Surg Oncol. 2010;17(0):297-302.
15. Olaya W, Wong JH, Morgan JW, Roy-Chowdhury S, Lum SS. Disparities in the surgical management of women with stage I breast cancer. Am Surg. 2009;75(10):869-72.
16. Mook S, Van't Veer LJ, Rutgers EJ, et al. Independent prognostic value of screen detection in invasive breast cancer. J Natl Cancer Inst. 2011;103(7):585-97.
17. Smart CR, Byrne C, Smith RA, et al. Twenty-year follow-up of the breast cancers diagnosed during the Breast Cancer Detection Demonstration Project. CA Cancer J Clin. 1997;47(3):134-49.
18. Shen Y, Yang Y, Inoue LY, Munsell MF, Miller AB, Berry DA. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials. J Natl Cancer Inst. 2005;97(16):1195-203.
19. Wishart GC, Greenberg DC, Britton PD, et al. Screen-detected versus symptomatic breast cancer: is improved survival due to stage migration alone? Br J Cancer. 2008;98(11):1741-4.
20. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L. (2009) Screening for breast cancer: an update for the U. S. Preventive Services Task Force. Ann Intern Med. 151(10):727-37, W237-742.
21. Kopans DB. The 2009 US Preventive Services Task Force (US-PSTF) guidelines are not supported by science: the scientific support for mammography screening. Radiol Clin North Am. 2010;48(5):843-57.
22. Hendrick RE, Helvie MA. United States Preventive Services Task Force screening mammography recommendations: science ignored. AJR Am J Roentgenol. 2011;196(2):W112-6.
23. Miranda PY, Wilkinson AV, Etzel CJ, et al. Policy implications of early onset breast cancer among Mexican-origin women. Cancer. 2011;117(2):390-7.
24. Risendal B, Hines LM, Sweeney C, et al. Family history and age at onset of breast cancer in Hispanic and non-Hispanic white women. Cancer Causes Control. 2008;19(10):1349-55.
25. Innos K, Horn-Ross PL. Recent trends and racial/ethnic differences in the incidence and treatment of ductal carcinoma in situ of the breast in California women. Cancer. 2003;97(4):1099-106.
26. U. S. Census Bureau (2010). http://2010.census.gov/2010census/Accessed 1 April, 2011.
27. Nassar H, Sharafaldeen B, Visvanathan K, Visscher D. Ductal carcinoma in situ in African American versus Caucasian American women: analysis of clinicopathologic features and outcome. Cancer. 2009;115(14):3181-8.
28. Hofer BM KS, Allen M, Bates JH, McCusker ME, Snipes KP. Cancer in California, 2008, special highlight on cancer by race and ethnicity. Sacramento, CA: California Department of Public Health, Cancer Surveillance Section.
29. Smith-Bindman R, Miglioretti DL, Lurie N, et al. Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med. 2006;144(8):541-53.
30. Hahn KM, Bondy ML, Selvan M, et al. Factors associated with advanced disease stage at diagnosis in a population-based study of patients with newly diagnosed breast cancer. Am J Epidemiol. 2007;166(9):1035-44.
31. Wells BL, Horm JW. Stage at diagnosis in breast cancer: race and socioeconomic factors. Am J Public Health. 1992;82(10):1383-5.
32. Bradley CJ, Given CW, Roberts C. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst. 2002;94(7):490-6.
33. Parise CA, Bauer KR, Brown MM, Caggiano V. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004. Breast J. 2009;15(6):593-602.
34. Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006;295(21):2492-502.
35. Health and Safety Code Section 103875-103885. http://www.leg. infoca.gov/cgi-bin/displaycode?section=hsc&group=103001-104000&file= 103875-103885. Accessed 4 June, 2011.